Related references
Note: Only part of the references are listed.Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome
Shaokang Ma et al.
ONCOIMMUNOLOGY (2020)
Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for in flammatory diseases
Wei He et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges
Eileen McGowan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
PIRs mediate innate myeloid cell memory to nonself MHC molecules
Hehua Dai et al.
SCIENCE (2020)
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
Lan Wu et al.
NATURE CANCER (2020)
Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy
Fuming Chen et al.
BIOMATERIALS (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
Weijing Yang et al.
ACS NANO (2019)
Artificially cloaked viral nanovaccine for cancer immunotherapy
Manlio Fusciello et al.
NATURE COMMUNICATIONS (2019)
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
NATURE REVIEWS CANCER (2019)
Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy
Pedro P. G. Guimaraes et al.
ACS NANO (2018)
ROS-Inducing Micelles Sensitize Tumor-Associated Macrophages to TLR3 Stimulation for Potent Immunotherapy
Lanlan Liu et al.
BIOMACROMOLECULES (2018)
Cell Therapy for Nonischemic Cardiomyopathy: Current Status and Future Perspectives
Bojan Vrtovec
CIRCULATION RESEARCH (2018)
New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types
Marcin Wysoczynki et al.
CIRCULATION RESEARCH (2018)
General and Facile Coating of Single Cells via Mild Reduction
Hyunbum Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy
Yu Zhang et al.
NANO LETTERS (2018)
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
Degao Chen et al.
NATURE COMMUNICATIONS (2018)
Macrophages loaded CpG and GNR-PEI for combination of tumor photothermal therapy and immunotherapy
Jie Chen et al.
SCIENCE CHINA-MATERIALS (2018)
Pretreated Macrophage-Membrane-Coated Gold Nanocages for Precise Drug Delivery for Treatment of Bacterial Infections
Can Wang et al.
ADVANCED MATERIALS (2018)
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
Marieke F. Fransen et al.
JCI INSIGHT (2018)
Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles
Lang Rao et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2017)
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
Oladapo O. Yeku et al.
SCIENTIFIC REPORTS (2017)
Cancer Cell Membrane-Biomimetic Oxygen Nanocarrier for Breaking Hypoxia-Induced Chemoresistance
Hao Tian et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
The Principles of Engineering Immune Cells to Treat Cancer
Wendell A. Lim et al.
CELL (2017)
Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy
Mingjun Xuan et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
Haiqiang Cao et al.
ACS NANO (2016)
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
Andy J. Minn et al.
CELL (2016)
Lymph node - an organ for T-cell activation and pathogen defense
Georg Gasteiger et al.
IMMUNOLOGICAL REVIEWS (2016)
Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy
Jingxing Si et al.
SMALL (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
Sravan Kumar Patel et al.
THERANOSTICS (2015)
Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
Minjun Xuan et al.
ADVANCED HEALTHCARE MATERIALS (2015)
CAR-T cell therapy seeks strategies to harness cytokine storm
Laura DeFrancesco
NATURE BIOTECHNOLOGY (2014)
Cytokines as biomarkers of nanoparticle immunotoxicity
Mahmoud Elsabahy et al.
CHEMICAL SOCIETY REVIEWS (2013)
Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles
Dan Peer
ADVANCED DRUG DELIVERY REVIEWS (2012)
Surface markers of lymphocyte activation and markers of cell proliferation
Maria Shipkova et al.
CLINICA CHIMICA ACTA (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
Qing Chen et al.
CANCER CELL (2011)
Double-stranded RNA induces melanocyte death via activation of Toll-like receptor 3
Ning Yu et al.
EXPERIMENTAL DERMATOLOGY (2011)
Toll-like Receptor 3 (TLR3) Induces Apoptosis via Death Receptors and Mitochondria by Up-regulating the Transactivating p63 Isoform α (TAP63α)
Ruili Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Labile disulfide bonds are common at the leucocyte cell surface
Clive Metcalfe et al.
OPEN BIOLOGY (2011)
Anticancer function of polyinosinic-polycytidylic acid
Yu-Sheng Cheng et al.
CANCER BIOLOGY & THERAPY (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
Qun Jiang et al.
BMC CANCER (2008)
The use of dendritic cells in cancer immunotherapy
Alessio Nencioni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors
Mi-Ran Choi et al.
NANO LETTERS (2007)
TLR3 can directly trigger apoptosis in human cancer cells
Bruno Salaun et al.
JOURNAL OF IMMUNOLOGY (2006)
Share Paper
